Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

The Dendritic Cell System and its Role in Immunogenicity

1991 • 4,733 citations

Cellular and Molecular Immunology

1994 • 3,469 citations

Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

1996 • 1,854 citations

MHC ligands and peptide motifs: first listing

1995 • 1,674 citations

The Biochemistry and Cell Biology of Antigen Processing and Presentation

1993 • 1,022 citations

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

1994 • 838 citations

Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice

1992 • 650 citations

Identification of human cancers deficient in antigen processing.

1993 • 625 citations

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

1992 • 410 citations

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1996 • 398 citations

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

1993 • 385 citations

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

1995 • 367 citations

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

1993 • 344 citations

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.

1986 • 305 citations

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1995 • 264 citations

Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.

1987 • 237 citations

Dendritic Cells in Antitumor Immune Responses

1996 • 219 citations

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides.

1996 • 215 citations

Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.

1990 • 210 citations

Alterations in T cell receptor and signal transduction molecules in melanoma patients.

1995 • 192 citations

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1997 • 126 citations

Interleukin 10 production by human melanoma.

1996 • 113 citations

Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.

1994 • 112 citations

Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.

1996 • 101 citations

Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cells

1990 • 98 citations

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1992 • 89 citations

Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.

1995 • 78 citations

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

1994 • 71 citations

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

1995 • 62 citations

Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model

1996 • 59 citations

In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy

1995 • 51 citations

Differential Effect of Human Immunodeficiency Virus Infection on the IgA and IgG Antibody Responses to Pneumococcal Vaccine

1995 • 48 citations

Tumor antigens and tumor vaccines: Peptides as immunogens

1996 • 48 citations

Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.

1990 • 35 citations

Salvage immunotherapy with subcutaneous recombinant interleukin 2 (rIL-2) and alpha-interferon (A-IFN) for stage D3 prostate carcinoma failing second-line hormonal treatment

1996 • 24 citations

Relevance of the T cell receptor for immunotherapy of cancer

1994 • 13 citations

Human leukocyte antigen subtype analysis in patients with advanced adenocarcinoma of the prostate

1994 • 6 citations

Detection of Soluble T Cell Receptor-Releasing Cells by ELISPOT Assay

1995 • 4 citations